Back to mobile site

UPDATE: BTIG Upgrades Verastem (VSTM) to Buy on FDA Breakthrough Designation

May 24, 2021 11:48 AM EDT Send to a Friend
(Updated - May 24, 2021 11:51 AM EDT)

BTIG analyst Robert Hazlett upgraded Verastem (NASDAQ: VSTM) from Neutral to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login